Skip to content

VETPHARM

Active Private limited companyfounded 2011active for 15 yearsKokelarestraat 83, 8870 IzegemKBO/BCE: BE 0839.331.991 subsidiary of

Lifetime

14 annual accounts with figures on one time axis
peak of €844,896 in 2018
€124,072▼ 75.5%
peak of €397,060 in 2018
€31,770▼ 91.6%
peak of €937,060 in 2025
€937,060▲ 3.5%
€4.6m▼ 24.0%
peak of 3.9 FTE in 2018
-not published
Board2 names since 2016
2 directors and 1 other
Owners
consolidates
Documentsfilings and deeds
10-06-202651 days before the deadline
2025abbreviated format
Gross margin from €505,635 to €124,072Result from €376,696 to €31,770Registered office moved within Izegem 06-10Debts from €6.1m to €4.6mInvestments €29,637Cash from €12,618 to €67,101

Key points

from the 2025 annual accounts

Equity

€937,060 ▲ 3.5%

VETPHARM has made a profit in every financial year since 2012.

Result

€31,770 ▼ 91.6%
€377,0002024€31,8002025

The result fell in 2025 from €376,696 to €31,770.

Turnover

≈ €690,000 estimated

The abbreviated format states no turnover.

Debts

€4.6m 83% of the balance sheet
Financial debts 22%Suppliers 61%Other 17%

Of this, €4.5m falls due within a year.

Investments

€31,137 2.0 times depreciation
2021202220242025

Green is investment, beige is depreciation.

Filings

14 annual accounts since 2012
AprilJune31 JulyOctober201520202025

The last five annual accounts were filed 37 to 51 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 4,109 companies had the same profile as VETPHARM has now. Each dot stands for 11 companies, two years later.

97.9%
were still trading
0.9%
stopped another way
1.1%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 4,109 companies, not a prediction for VETPHARM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager,
Director
  • consolidatesannual accounts 2025

Shares in 1 company,

Board & ownership

Recent changes

Registered office moved within Izegem The registered office moved from Oude Iepersestraat 88, 8870 Izegem to Kokelarestraat 83, 8870 Izegem · acts as permanent representative · Gazette deed
and act as permanent representatives changes role from manager to director · Discharge granted to (manager) · holds all the shares · General meeting of 02-12-2022 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0839331991
1 manager appointed, 2 resignations (manager) and (manager) resign · appointed as manager · acts as permanent representative · General meeting of 31-12-2016 · Gazette deed
All 24 events

Comparable companies

same main activity, similar in size and age
Company
VETPHARM Izegem €5.6m €124,072 16.8% -
RevaTis Marche-en-Famenne €4.1m €136,602 62.0% -
PATRICIA BASTIEN Wellin €5.3m €267,605 39.3% 0.2
LMT Kortrijk €5.7m €387,208 5.3% 0
CREDOPHAR Ghent €7.8m €257,722 24.6% -
NEW TECH BENELUX Mouscron €2.5m €196,073 26.6% 1.2
SOS OXYGENE BENELUX Nivelles €4.9m €44,933 -58.4% 9.4

These companies have the same main activity as VETPHARM: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €2.5m and €7.8m, founded between 2010 and 2013.

Official details

Source: KBO
Status
Active since 26-08-2011Normal situation
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Establishment unit
2.237.200.9718870 Izegem, since 15-12-2014
Financial year end
31 December
Peppol
Reachable since 20-11-2020
Company details

Annual accounts 2025

€5.6m▼ 20.4%
Filing
Filed on 10-06-2026, 51 days before the end of the filing period
Financials

Insights on VETPHARM

VETPHARM files the abbreviated format. That format states no turnover. The gross margin rose from €40,534 in 2012 to €124,072 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about VETPHARM

What is the company number of VETPHARM?
The company number of VETPHARM is 0839.331.991. The VAT number is the same number with BE in front: BE 0839.331.991.
Where is VETPHARM based?
The registered office is at Kokelarestraat 83, 8870 Izegem.Company details
What does VETPHARM do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of VETPHARM?
VETPHARM is a private limited company (BV).
When was VETPHARM founded?
VETPHARM was founded on 26-08-2011.
Is VETPHARM still active?
Yes, VETPHARM is an active enterprise in the KBO register.
How many employees does VETPHARM have?
VETPHARM had an average of 0.3 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of VETPHARM?
The turnover in financial year 2025 is about €690,000. This figure is estimated from the gross margin of €124,072 and 85 comparable companies (NACE 46). It probably lies between €290,000 and €1.2m.
Is VETPHARM profitable?
In financial year 2025, VETPHARM made a profit of €31,770.
Where can I find the annual accounts of VETPHARM?
VETPHARM filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of VETPHARM due?
VETPHARM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.